HNO
3
(μg/m
3
): size of interquartile range 1.3
| | | | | |
ΔPEF | | | | | |
Morning | | | | | |
Effect size | −1.09 | 0.53 | 0.72 | 2.26* | −0.59 |
Upper 95% CI | 1.07 | 2.81 | 3.06 | 4.43 | 6.14 |
Lower 95% CI | −3.26 | −1.74 | −1.62 | 0.08 | −7.31 |
Afternoon | | | | | |
Effect size | −0.08 | −0.72 | 0.36 | −1.92 | −4.67 |
Upper 95% CI | 1.97 | 1.40 | 2.49 | 0.17 | 0.96 |
Lower 95% CI | −2.14 | −2.84 | −1.77 | −4.01 | −10.29 |
| | | | | |
Prevalent symptoms | | | | | |
Cough | | | | | |
Effect size | 1.09* | 1.01 | 0.94 | 0.89* | 0.66* |
Upper 95% CI | 1.19 | 1.11 | 1.03 | 0.97 | 0.88 |
Lower 95% CI | 1.00 | 0.92 | 0.86 | 0.82 | 0.49 |
Ill | | | | | |
Effect size | 0.92 | 0.98 | 0.95 | 1.04 | 0.79 |
Upper 95% CI | 1.04 | 1.12 | 1.08 | 1.18 | 1.34 |
Lower 95% CI | 0.83 | 0.86 | 0.83 | 0.92 | 0.46 |
SOB | | | | | |
Effect size | 1.04 | 1.01 | 0.99 | 0.95 | 1.02 |
Upper 95% CI | 1.21 | 1.18 | 1.15 | 1.10 | 1.61 |
Lower 95% CI | 0.90 | 0.86 | 0.85 | 0.82 | 0.65 |
Wake | | | | | |
Effect size | 0.83* | 0.76* | 0.94 | 0.89 | 0.93 |
Upper 95% CI | 0.99 | 0.92 | 1.12 | 1.05 | 1.73 |
Lower 95% CI | 0.69 | 0.62 | 0.78 | 0.75 | 0.50 |
Wheeze | | | | | |
Effect size | 0.93 | 0.87 | 0.87 | 0.7* | 0.71 |
Upper 95% CI | 1.09 | 1.02 | 1.04 | 0.82 | 1.20 |
Lower 95% CI | 0.80 | 0.74 | 0.73 | 0.60 | 0.43 |
| | | | | |
SO
4
2−
(μg/m
3
): size of interquartile range 3.1
| | | | | |
ΔPEF | | | | | |
Morning | | | | | |
Effect size | −0.72 | −1.69 | 1.35 | 3.38* | 2.98 |
Upper 95% CI | 1.82 | 0.90 | 3.97 | 5.72 | 10.13 |
Lower 95% CI | −3.27 | −4.28 | −1.27 | 1.03 | −4.17 |
Afternoon | | | | | |
Effect size | −0.32 | 0.84 | −0.08 | −0.25 | −2.20 |
Upper 95% CI | 2.17 | 3.30 | 2.44 | 2.19 | 5.12 |
Lower 95% CI | −2.81 | −1.63 | −2.61 | −2.69 | −9.51 |
| | | | | |
Prevalent symptoms | | | | | |
Cough | | | | | |
Effect size | 1.08 | 1.03 | 0.97 | 0.9* | 0.73* |
Upper 95% CI | 1.20 | 1.15 | 1.07 | 0.99 | 0.97 |
Lower 95% CI | 0.98 | 0.93 | 0.88 | 0.82 | 0.54 |
Ill | | | | | |
Effect size | 0.98 | 0.97 | 1.01 | 0.95 | 0.72 |
Upper 95% CI | 1.11 | 1.12 | 1.16 | 1.09 | 1.12 |
Lower 95% CI | 0.86 | 0.84 | 0.88 | 0.84 | 0.46 |
SOB | | | | | |
Effect size | 0.95 | 1.07 | 1.04 | 0.94 | 0.58 |
Upper 95% CI | 1.14 | 1.28 | 1.24 | 1.12 | 1.04 |
Lower 95% CI | 0.80 | 0.89 | 0.87 | 0.80 | 0.33 |
Wake | | | | | |
Effect size | 0.95 | 0.81* | 0.93 | 0.87 | 0.77 |
Upper 95% CI | 1.16 | 0.99 | 1.13 | 1.05 | 1.48 |
Lower 95% CI | 0.78 | 0.67 | 0.76 | 0.72 | 0.41 |
Wheeze | | | | | |
Effect size | 0.97 | 1.09 | 1.00 | 0.81* | 1.30 |
Upper 95% CI | 1.17 | 1.32 | 1.22 | 0.97 | 2.50 |
Lower 95% CI | 0.80 | 0.89 | 0.82 | 0.69 | 0.68 |
| | | | | |
NO
3
−
(μg/m
3
): size of interquartile range 3.7
| | | | | |
ΔPEF | | | | | |
Morning | | | | | |
Effect size | −0.80 | 0.68 | 1.42 | 2.54* | 1.74 |
Upper 95% CI | 1.15 | 2.67 | 3.58 | 4.59 | 6.13 |
Lower 95% CI | −2.74 | −1.31 | −0.73 | 0.48 | −2.66 |
Afternoon | | | | | |
Effect size | −0.72 | −0.59 | −0.33 | 0.66 | 0.47 |
Upper 95% CI | 1.03 | 1.18 | 1.45 | 2.58 | 4.29 |
Lower 95% CI | −2.47 | −2.36 | −2.11 | −1.26 | −3.36 |
| | | | | |
Prevalent symptoms | | | | | |
Cough | | | | | |
Effect size | 1.05 | 1.01 | 0.95 | 0.89* | 0.81* |
Upper 95% CI | 1.13 | 1.10 | 1.03 | 0.96 | 0.97 |
Lower 95% CI | 0.97 | 0.93 | 0.88 | 0.83 | 0.68 |
Ill | | | | | |
Effect size | 0.97 | 0.98 | 0.95 | 0.94 | 0.74 |
Upper 95% CI | 1.09 | 1.10 | 1.06 | 1.05 | 1.03 |
Lower 95% CI | 0.87 | 0.87 | 0.85 | 0.85 | 0.54 |
SOB | | | | | |
Effect size | 1.04 | 1.12 | 1.04 | 0.90 | 1.06 |
Upper 95% CI | 1.18 | 1.28 | 1.20 | 1.03 | 1.43 |
Lower 95% CI | 0.90 | 0.98 | 0.90 | 0.79 | 0.78 |
Wake | | | | | |
Effect size | 0.94 | 0.86 | 0.94 | 0.92 | 0.95 |
Upper 95% CI | 1.09 | 1.01 | 1.11 | 1.07 | 1.47 |
Lower 95% CI | 0.80 | 0.72 | 0.79 | 0.79 | 0.62 |
Wheeze | | | | | |
Effect size | 1.01 | 0.96 | 0.95 | 0.87 | 1.04 |
Upper 95% CI | 1.17 | 1.11 | 1.10 | 1.01 | 1.60 |
Lower 95% CI | 0.87 | 0.83 | 0.82 | 0.75 | 0.67 |